相似文献
1
Radical irradiation of extracranial oligometastases.
J Clin Oncol. 2014 Sep 10;32(26):2902-12. doi: 10.1200/JCO.2014.55.9567. Epub 2014 Aug 11.
2
Novel stereotactic body radiation therapy (SBRT)-based partial tumor irradiation targeting hypoxic segment of bulky tumors (SBRT-PATHY): improvement of the radiotherapy outcome by exploiting the bystander and abscopal effects.
Radiat Oncol. 2019 Jan 29;14(1):21. doi: 10.1186/s13014-019-1227-y.
3
[Stereotactic body radiation therapy and oligometastases].
Cancer Radiother. 2014 Jul-Aug;18(4):337-41. doi: 10.1016/j.canrad.2014.02.008. Epub 2014 May 1.
4
New Strategies in Stereotactic Radiotherapy for Oligometastases.
Clin Cancer Res. 2015 Dec 1;21(23):5198-204. doi: 10.1158/1078-0432.CCR-15-0822.
5
Comparison of Single-fraction and Multi-fraction Stereotactic Radiotherapy for Patients with 18F-fluorodeoxyglucose Positron Emission Tomography-staged Pulmonary Oligometastases.
Clin Oncol (R Coll Radiol). 2015 Jun;27(6):353-61. doi: 10.1016/j.clon.2015.01.004. Epub 2015 Feb 16.
6
Physics and imaging for targeting of oligometastases.
Semin Radiat Oncol. 2006 Apr;16(2):85-101. doi: 10.1016/j.semradonc.2005.12.004.
7
Principles and Applications of Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy.
Hematol Oncol Clin North Am. 2019 Dec;33(6):977-987. doi: 10.1016/j.hoc.2019.08.007. Epub 2019 Sep 27.
8
A multinational report of technical factors on stereotactic body radiotherapy for oligometastases.
Future Oncol. 2017 May;13(12):1081-1089. doi: 10.2217/fon-2016-0479. Epub 2017 Feb 3.
9
Oligometastases: history of a hypothesis.
Ann Palliat Med. 2021 May;10(5):5923-5930. doi: 10.21037/apm.2020.03.31. Epub 2020 Mar 31.
10
Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients.
Radiat Oncol. 2020 Feb 4;15(1):30. doi: 10.1186/s13014-020-1480-0.
引用本文的文献
1
Survival Benefit of Synchronous Lenvatinib Combined PD-1 Inhibitors for Advanced Hepatocellular Carcinoma Beyond Oligometastasis.
Immunotargets Ther. 2024 Jun 17;13:305-317. doi: 10.2147/ITT.S458700. eCollection 2024.
2
Predicting long‑term survival following involved site radiotherapy for oligometastases.
Oncol Lett. 2024 Jan 5;27(2):82. doi: 10.3892/ol.2024.14216. eCollection 2024 Feb.
3
Total ablative stereotactic body radiotherapy to primary and oligometastatic renal cell carcinoma in medically inoperable cases: An institutional analysis.
Indian J Urol. 2023 Oct-Dec;39(4):303-310. doi: 10.4103/iju.iju_104_23. Epub 2023 Sep 29.
4
Effectiveness of lenvatinib plus immune checkpoint inhibitors in primary advanced hepatocellular carcinoma beyond oligometastasis.
Clin Transl Med. 2023 Mar;13(3):e1214. doi: 10.1002/ctm2.1214.
5
Management of Oligometastatic Breast Cancer: An Expert Committee's Opinion.
Curr Oncol. 2023 Jan 19;30(2):1416-1425. doi: 10.3390/curroncol30020108.
6
Unravelling oligometastatic disease from the perspective of radiation and medical oncology. Part I: non-small cell lung cancer and breast cancer.
Clin Transl Oncol. 2023 Apr;25(4):882-896. doi: 10.1007/s12094-022-03011-6. Epub 2022 Dec 16.
7
Unravelling oligometastatic disease from the perspective of radiation and medical oncology. Part II: prostate cancer and colorectal cancer.
Clin Transl Oncol. 2023 Apr;25(4):897-911. doi: 10.1007/s12094-022-03019-y. Epub 2022 Dec 16.
8
International consensus on radiotherapy in metastatic non-small cell lung cancer.
Transl Lung Cancer Res. 2022 Sep;11(9):1763-1795. doi: 10.21037/tlcr-22-644.
9
Case Report: Extensive Tumor Profiling in Primary Neuroendocrine Breast Cancer Cases as a Role Model for Personalized Treatment in Rare and Aggressive Cancer Types.
Front Med (Lausanne). 2022 Jun 3;9:841441. doi: 10.3389/fmed.2022.841441. eCollection 2022.
10
Comparing Outcomes of Oligometastases Treated with Hypofractionated Image-Guided Radiotherapy (HIGRT) with a Simultaneous Integrated Boost (SIB) Technique versus Metastasis Alone: A Multi-Institutional Analysis.
Cancers (Basel). 2022 May 13;14(10):2403. doi: 10.3390/cancers14102403.
本文引用的文献
1
Definitive Stereotactic Body Radiotherapy (SBRT) for Extracranial Oligometastases: An International Survey of >1000 Radiation Oncologists.
Am J Clin Oncol. 2017 Aug;40(4):418-422. doi: 10.1097/COC.0000000000000169.
2
Feasibility and toxicity of hypofractionated image guided radiation therapy for large volume limited metastatic disease.
Pract Radiat Oncol. 2013 Oct-Dec;3(4):316-22. doi: 10.1016/j.prro.2012.08.006. Epub 2012 Oct 3.
3
An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer.
Cancer Immunol Res. 2013 Dec;1(6):365-72. doi: 10.1158/2326-6066.CIR-13-0115.
4
Stereotactic radiation therapy can safely and durably control sites of extra-central nervous system oligoprogressive disease in anaplastic lymphoma kinase-positive lung cancer patients receiving crizotinib.
Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):892-8. doi: 10.1016/j.ijrobp.2013.11.010. Epub 2014 Jan 22.
5
Stereotactic body radiotherapy: a critical review for nonradiation oncologists.
Cancer. 2014 Apr 1;120(7):942-54. doi: 10.1002/cncr.28515. Epub 2013 Dec 30.
6
Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival.
Ann Oncol. 2014 Feb;25(2):467-71. doi: 10.1093/annonc/mdt537. Epub 2013 Dec 18.
7
Survival impact of surgical resection of primary tumor in patients with stage IV colorectal cancer: results from a large population-based cohort study.
Cancer. 2014 Mar 1;120(5):683-91. doi: 10.1002/cncr.28464. Epub 2013 Nov 12.
8
Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature.
Lung Cancer. 2013 Nov;82(2):197-203. doi: 10.1016/j.lungcan.2013.07.026. Epub 2013 Aug 20.
9
Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors.
Lung Cancer. 2013 Oct;82(1):95-102. doi: 10.1016/j.lungcan.2013.07.023. Epub 2013 Aug 6.
10
Vertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score.
J Clin Oncol. 2013 Sep 20;31(27):3426-31. doi: 10.1200/JCO.2013.50.1411. Epub 2013 Aug 19.
Zotero 插件